CD36 and obesity disorder: In addition, OEA can modulate an increase in the expression level of fatty acid translocase CD36, subsequently regulating feeding behavior and inducing a sense of satiety, thereby having the potential to emerge as a promising therapeutic approach for anti-obesity and hypolipidemic treatments [42].